Vident Investment Advisory, LLC Bicycle Therapeutics PLC Transaction History

Vident Investment Advisory, LLC

  • $0
  • Q3 2023

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
BUY
$20.02 - $31.37 $6,606 - $10,352
330 Added 1.38%
24,287 $516,000
Q4 2022

Feb 14, 2023
BUY
$20.37 - $32.9 $488,004 - $788,185
23,957 New
23,957 $709,000
Q2 2022

Aug 15, 2022
SELL
$12.95 - $46.99 $279,357 - $1.01 Million
-21,572 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$40.12 - $59.5 $145,996 - $216,520
3,639 Added 20.29%
21,572 $947,000
Q4 2021

Feb 14, 2022
BUY
$41.7 - $61.14 $747,806 - $1.1 Million
17,933 New
17,933 $1.09 Million

Others Institutions Holding BCYC

# of Institutions
111
Shares Held
40.8M
Call Options Held
39.6K
Put Options Held
24.6K
View Full List

About BICYCLE THERAPEUTICS plc

BCYC Quotes by TradingView
  • Ticker BCYC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,676,100
  • Market Cap $433M
  • Description
  • Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Its lead product candidate is BT1718, a bicycle toxin conjugate (BTC), which is in Phase I/IIa clinical trials targeting tumors that express Membrane Type 1 matrix metalloprotease. The co...
More about BCYC
Track This Portfolio

Track Vident Investment Advisory, LLC Portfolio

Follow Vident Investment Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vident Investment Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vident Investment Advisory, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email